Newsroom

latest news from ose
and across our portfolio

Featured News

Oxford Spinout Oxford Semantic Technologies acquired by Samsung Electronics
Oxford Spinout Oxford Semantic Technologies acquired by Samsung ElectronicsArticle links to www.oxionics.com
Oxford Ionics breaks global quantum performance records
Oxford Ionics breaks global quantum performance records
Times Commentary: Science innovation must be at the heart of government action
Times Commentary: Science innovation must be at the heart of government actionArticle links to www.beacontx.com
Beacon Therapeutics Raises $170 Million in Series B Funding to Advance Development of Ophthalmic Gene Therapies
Beacon Therapeutics Raises $170 Million in Series B Funding to Advance Development of Ophthalmic Gene TherapiesArticle links to www.prnewswire.com
PQShield raises $37m in Series B funding to deliver the widespread commercial adoption of quantum resistant cryptography
PQShield raises $37m in Series B funding to deliver the widespread commercial adoption of quantum resistant cryptographyArticle links to www.globenewswire.com
Amber Therapeutics Closes $100 Million Series A - one of the largest European MedTech raises
Amber Therapeutics Closes $100 Million Series A - one of the largest European MedTech raisesArticle links to www.businesswire.com
SpyBiotech Adds Epstein-Barr Virus Research and Development Collaboration with The University of Oxford
SpyBiotech Adds Epstein-Barr Virus Research and Development Collaboration with The University of Oxford
OSE announces groundbreaking new partnership with The Crown Estate and Pioneer Group
OSE announces groundbreaking new partnership with The Crown Estate and Pioneer Group

All News

Portfolio NewsCaristo DiagnosticsMichel Lussier Joins Caristo Diagnostics Board of DirectorsPortfolio NewsCaristo DiagnosticsCaristo Diagnostics Wins Digital Health Award for CaRi-Heart® Cardiac Risk Prediction TechnologyPortfolio NewsCaristo DiagnosticsNewsweek Selects Caristo Diagnostics as One of World's Best Digital Health CompaniesPortfolio NewsCaristo DiagnosticsAgepha Pharma and Caristo Diagnostics Team Up to Fight Coronary InflammationPortfolio NewsCaristo DiagnosticsAmerican Heart Association Presentation found that AI technology used by Caristo can predict fatal and not-fatal cardiac eventsPortfolio NewsCaristo DiagnosticsBritish Heart Foundation Features Breakthrough Heart Attack Prevention Technology in Online News Programme for World Heart DayPortfolio NewsCaristo DiagnosticsCaristo Diagnostics Piloting New Cardiac Disease Diagnostic Technology in UK NHS HospitalsPortfolio NewsCaristo DiagnosticsCaristo Diagnostics Applauds FDA Approval of Colchicine as First Anti-Inflammatory Drug for Cardiovascular DiseasePortfolio NewsCaristo DiagnosticsCaristo Diagnostics Completes Series A Financing and Welcomes New CEOPortfolio NewsCaristo DiagnosticsCaristo Diagnostics announces CT coronary perivascular fat assessment can stratify cardiac risk associated with high-risk plaquesPortfolio NewsCaristo DiagnosticsCaristo Diagnostics announces EU approval for AI technology which can predict heart attacks years in advance